New Hampshire

New Hampshire has rapidly emerged as a premier life sciences hub, leveraging its proximity to Boston to create a high-growth, cost-effective ecosystem for biotechnology and pharmaceutical manufacturing.

The state is internationally recognized for its leadership in regenerative medicine and advanced biomanufacturing, anchored by the Advanced Regenerative Manufacturing Institute (ARMI) in Manchester's historic Millyard. Global leaders like Lonza, Novo Nordisk and MilliporeSigma drive the state's robust bioprocessing and drug development sectors, benefiting from a business-friendly, low-tax environment.

In the medical device sector, New Hampshire excels in precision engineering and medtech innovation, with specialized firms producing next-generation diagnostic tools and surgical technologies.

Healthcare innovation is further propelled by Dartmouth Health and the Geisel School of Medicine, which lead groundbreaking clinical research and translational medicine initiatives.

The University of New Hampshire (UNH) supports the ecosystem through the Hubbard Center for Genome Studies, providing critical genomics and bioinformatics resources.

New Hampshire's life sciences workforce is one of the fastest-growing in the US, supported by the ReGen Valley initiative, which integrates academic excellence with industrial scale. This collaborative network ensures a seamless pipeline from lab-to-market, making the Granite State a top destination for life sciences investment and startup incubation.

By combining world-class academic research with advanced commercial manufacturing, New Hampshire is redefining the future of personalized medicine and healthcare delivery on a global scale.